🇺🇸 FDA
Patent

US 10034919

Targeted human-interferon fusion proteins

granted A61KA61K38/212A61K47/6813

Quick answer

US patent 10034919 (Targeted human-interferon fusion proteins) held by Universite Montepellier 2 expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Universite Montepellier 2
Grant date
Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/212, A61K47/6813, A61P, A61P19/00